A6T-31113-34246
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 328 / FL
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Moderna
- 2021-04-12
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-17
- 2021-04-18
-
2021-04-19
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: Good · HeadacheFree text: Lymph node swelling in underarmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-05-03
-
2021-05-10
Dose 2 — Moderna
-
2021-05-10
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-24
- 2021-06-01
-
2021-06-07
Survey response — day 28, dose 2MedDRA: Headache, Insomnia, Menstruation irregular, Night sweats — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Irregular menstrual periodPersistent headacheNight sweatsSleeplessnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-14
Survey response — day 35, dose 2MedDRA: Headache, Heavy menstrual bleeding — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Abnormally long menstrual period, a second menstrual period within 1 week of the first menstrual period, persistent headache over 5+ days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-21
Survey response — day 42, dose 2MedDRA: Night sweats — Feeling: Good · Be unable to do your normal daily activitiesFree text: 3-week long moderate-to-heavy menstrual bleeding, with a very shortened overall menstrual cycle -- only one week in between bleeding. Continued night sweats and interrupted sleep.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-09
- 2021-11-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Moderna | |
| 2 | 2021-05-10 | Moderna |
Free text
Release 7 — day 7, dose 1
Systemic reaction (other): Lymph node swelling in underarm
Release 8 — day 28, dose 2
Symptoms: Irregular menstrual periodPersistent headacheNight sweatsSleeplessness
Release 9 — day 35, dose 2
Symptoms: Abnormally long menstrual period, a second menstrual period within 1 week of the first menstrual period, persistent headache over 5+ days.
Release 9 — day 42, dose 2
Symptoms: 3-week long moderate-to-heavy menstrual bleeding, with a very shortened overall menstrual cycle -- only one week in between bleeding. Continued night sweats and interrupted sleep.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SD | Night sweats | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release